BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10606619)

  • 1. The arrival of HLA class II tetramers.
    McMichael AJ; Kelleher A
    J Clin Invest; 1999 Dec; 104(12):1669-70. PubMed ID: 10606619
    [No Abstract]   [Full Text] [Related]  

  • 2. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.
    Novak EJ; Liu AW; Nepom GT; Kwok WW
    J Clin Invest; 1999 Dec; 104(12):R63-7. PubMed ID: 10606632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4(+) T cells in healthy volunteers.
    Ye M; Kasey S; Khurana S; Nguyen NT; Schubert S; Nugent CT; Kuus-Reichel K; Hampl J
    Hum Immunol; 2004 May; 65(5):507-13. PubMed ID: 15172451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
    Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
    Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
    Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
    PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation.
    Raeiszadeh M; Pachnio A; Begum J; Craddock C; Moss P; Chen FE
    Haematologica; 2015 Aug; 100(8):e318-22. PubMed ID: 25975839
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.
    Topham DJ; Tripp RA; Sarawar SR; Sangster MY; Doherty PC
    J Virol; 1996 Feb; 70(2):1288-91. PubMed ID: 8551597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antigenic drift residues in influenza hemagglutinins of the H3 subtype qualify as contact sites for MHC class II interaction?
    Graham CM; Warren AP; Thomas DB
    Int Immunol; 1992 Aug; 4(8):917-22. PubMed ID: 1358189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands.
    Nicholas B; Bailey A; Staples KJ; Wilkinson T; Elliott T; Skipp P
    PLoS Pathog; 2022 Jan; 18(1):e1009894. PubMed ID: 35051231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: MHC class II-restricted killing in vivo during viral infection.
    Jellison ER; Kim SK; Welsh RM
    J Immunol; 2005 Jan; 174(2):614-8. PubMed ID: 15634878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral strategies of interference with MHC functions].
    Ishido S; Goto E; Sato Y; Hotta H
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
    Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
    J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of different lymphocyte subsets in human anti-viral T cell cultures.
    Gomez A; Bourgault I; Gomard E; Picard F; Levy JP
    Cell Immunol; 1989 Feb; 118(2):312-27. PubMed ID: 2562930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
    Cho KJ; Ishido S; Eisenlohr LC; Roche PA
    J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restriction analysis of influenza-specific cloned cell lines issued from an HLA-DRw6/DR- donor.
    Sterkers G; Michon J; Lepage V; Henin Y; Muller JY; Degos L; Levy JP
    Immunogenetics; 1984; 20(6):693-7. PubMed ID: 6334648
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.
    Thomas DB; Hodgson J; Riska PF; Graham CM
    J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
    Niezold T; Storcksdieck Genannt Bonsmann M; Maaske A; Temchura V; Heinecke V; Hannaman D; Buer J; Ehrhardt C; Hansen W; Überla K; Tenbusch M
    Immunology; 2015 Aug; 145(4):519-33. PubMed ID: 25819746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells.
    Nepom GT; Buckner JH; Novak EJ; Reichstetter S; Reijonen H; Gebe J; Wang R; Swanson E; Kwok WW
    Arthritis Rheum; 2002 Jan; 46(1):5-12. PubMed ID: 11817608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.